Skip to main content
Journal cover image

Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease.

Publication ,  Journal Article
Zigler, CK; Li, Z; Hernandez, A; Randell, RL; Mann, CM; Weitzman, E; Schanberg, LE; von Scheven, E; Reeve, BB
Published in: Qual Life Res
December 2024

PURPOSE: Meaningful score differences (MSDs), as defined by recent FDA guidance, can improve the interpretation of outcome measure scores and score changes. Well-accepted methods for estimating MSDs typically rely on external anchor variables, but the applications of these methods are limited in children and adolescents with rheumatic diseases. This project explored multiple candidate anchors for the PROMIS® Pediatric measures of Physical Activity, Fatigue, Pain Interference, and Mobility for children with juvenile idiopathic arthritis (JIA) or systemic lupus erythematosus (SLE). METHODS: Longitudinal data were extracted from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Candidate anchors included patient-reported domain-specific global impressions of change (GIC) along with other parent- and clinician-reported variables. Prior to MSD estimation, the quality of the anchors was assessed using a priori criteria (correlation ≥0.30, n≥10, <10% missing). Anchors meeting criteria were used to calculate MSDs. RESULTS: Among 289 children with JIA and 47 with SLE, the GIC did not meet criteria inhalf of the scenarios. Other candidate anchors performed slightly better. The calculated MSDs varied by external anchor across measures, diagnoses, and direction of change (better vs worse). CONCLUSIONS: Many of the candidate external anchoring variables did not meet pre-specified criteria for calculating MSDs. Even for those that did, the choice of anchoring variable had a strong impact on the estimated MSD value and were different from other published values. As in adults, establishing pediatric MSDs requires selection of high-quality anchors, as changes in the variables used as anchors can impact MSD values and any subsequent score interpretations.

Duke Scholars

Published In

Qual Life Res

DOI

EISSN

1573-2649

Publication Date

December 2024

Volume

33

Issue

12

Start / End Page

3449 / 3457

Location

Netherlands

Related Subject Headings

  • Surveys and Questionnaires
  • Severity of Illness Index
  • Rheumatic Diseases
  • Registries
  • Quality of Life
  • Psychometrics
  • Patient Reported Outcome Measures
  • Male
  • Lupus Erythematosus, Systemic
  • Longitudinal Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zigler, C. K., Li, Z., Hernandez, A., Randell, R. L., Mann, C. M., Weitzman, E., … Reeve, B. B. (2024). Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease. Qual Life Res, 33(12), 3449–3457. https://doi.org/10.1007/s11136-024-03800-2
Zigler, C. K., Z. Li, A. Hernandez, R. L. Randell, C. M. Mann, E. Weitzman, L. E. Schanberg, E. von Scheven, and B. B. Reeve. “Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease.Qual Life Res 33, no. 12 (December 2024): 3449–57. https://doi.org/10.1007/s11136-024-03800-2.
Zigler CK, Li Z, Hernandez A, Randell RL, Mann CM, Weitzman E, et al. Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease. Qual Life Res. 2024 Dec;33(12):3449–57.
Zigler, C. K., et al. “Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease.Qual Life Res, vol. 33, no. 12, Dec. 2024, pp. 3449–57. Pubmed, doi:10.1007/s11136-024-03800-2.
Zigler CK, Li Z, Hernandez A, Randell RL, Mann CM, Weitzman E, Schanberg LE, von Scheven E, Reeve BB. Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease. Qual Life Res. 2024 Dec;33(12):3449–3457.
Journal cover image

Published In

Qual Life Res

DOI

EISSN

1573-2649

Publication Date

December 2024

Volume

33

Issue

12

Start / End Page

3449 / 3457

Location

Netherlands

Related Subject Headings

  • Surveys and Questionnaires
  • Severity of Illness Index
  • Rheumatic Diseases
  • Registries
  • Quality of Life
  • Psychometrics
  • Patient Reported Outcome Measures
  • Male
  • Lupus Erythematosus, Systemic
  • Longitudinal Studies